View in EDS

Advantages of a dual-tracer model over reference tissue models for binding potential measurement in tumors.

Saved in:
Bibliographic Details
Title: Advantages of a dual-tracer model over reference tissue models for binding potential measurement in tumors.
Authors: Tichauer, K. M.1 kenneth.tichauer@dartmouth.edu, Samkoe, K. S.1,2, Klubben, W. S.1, Hasan, T.3, Pogue, B. W.1,2,3 brian.w.pogue@dartmouth.edu
Source: Physics in Medicine & Biology. 10/21/2012, Vol. 57 Issue 20, p6647-6659. 13p.
Subjects: Tracers (Biology), Tissues -- Models, Epidermal growth factor receptors, Tumor treatment, Molecular biology, Gene expression, Hemodynamics
Abstract: The quantification of tumor molecular expression in vivo could have a significant impact for informing and monitoring emerging targeted therapies in oncology. Molecular imaging of targeted tracers can be used to quantify receptor expression in the form of a binding potential (BP) if the arterial input curve or a surrogate of it is also measured. However, the assumptions of the most common approaches (reference tissue models) may not be valid for use in tumors. In this study, the validity of reference tissue models is investigated for use in tumors experimentally and in simulations. Three different tumor lines were grown subcutaneously in athymic mice and the mice were injected with a mixture of an epidermal growth factor receptor-targeted fluorescent tracer and an untargeted fluorescent tracer. A one-compartment plasma input model demonstrated that the transport kinetics of both tracers was significantly different between tumors and all potential reference tissues, and using the reference tissuemodel resulted in a theoretical underestimation inBP of 50% ± 37%. On the other hand, the targeted and untargeted tracers demonstrated similar transport kinetics, allowing a dual-tracer approach to be employed to accurately estimate BP (with a theoretical error of 0.23% ± 9.07%). These findings highlight the potential for using a dual-tracer approach to quantify receptor expression in tumors with abnormal hemodynamics, possibly to inform the choice or progress of molecular cancer therapies. [ABSTRACT FROM AUTHOR]
© 2025 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved (Copyright applies to all Abstracts.)
Database: Engineering Source
FullText Text:
  Availability: 0
Header DbId: egs
DbLabel: Engineering Source
An: 82560195
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Advantages of a dual-tracer model over reference tissue models for binding potential measurement in tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Tichauer%2C+K%2E+M%2E%22">Tichauer, K. M.</searchLink><relatesTo>1</relatesTo><i> kenneth.tichauer@dartmouth.edu</i><br /><searchLink fieldCode="AR" term="%22Samkoe%2C+K%2E+S%2E%22">Samkoe, K. S.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Klubben%2C+W%2E+S%2E%22">Klubben, W. S.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hasan%2C+T%2E%22">Hasan, T.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Pogue%2C+B%2E+W%2E%22">Pogue, B. W.</searchLink><relatesTo>1,2,3</relatesTo><i> brian.w.pogue@dartmouth.edu</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Physics+in+Medicine+%26+Biology%22">Physics in Medicine & Biology</searchLink>. 10/21/2012, Vol. 57 Issue 20, p6647-6659. 13p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Tracers+%28Biology%29%22">Tracers (Biology)</searchLink><br /><searchLink fieldCode="DE" term="%22Tissues+--+Models%22">Tissues -- Models</searchLink><br /><searchLink fieldCode="DE" term="%22Epidermal+growth+factor+receptors%22">Epidermal growth factor receptors</searchLink><br /><searchLink fieldCode="DE" term="%22Tumor+treatment%22">Tumor treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Molecular+biology%22">Molecular biology</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+expression%22">Gene expression</searchLink><br /><searchLink fieldCode="DE" term="%22Hemodynamics%22">Hemodynamics</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The quantification of tumor molecular expression in vivo could have a significant impact for informing and monitoring emerging targeted therapies in oncology. Molecular imaging of targeted tracers can be used to quantify receptor expression in the form of a binding potential (BP) if the arterial input curve or a surrogate of it is also measured. However, the assumptions of the most common approaches (reference tissue models) may not be valid for use in tumors. In this study, the validity of reference tissue models is investigated for use in tumors experimentally and in simulations. Three different tumor lines were grown subcutaneously in athymic mice and the mice were injected with a mixture of an epidermal growth factor receptor-targeted fluorescent tracer and an untargeted fluorescent tracer. A one-compartment plasma input model demonstrated that the transport kinetics of both tracers was significantly different between tumors and all potential reference tissues, and using the reference tissuemodel resulted in a theoretical underestimation inBP of 50% ± 37%. On the other hand, the targeted and untargeted tracers demonstrated similar transport kinetics, allowing a dual-tracer approach to be employed to accurately estimate BP (with a theoretical error of 0.23% ± 9.07%). These findings highlight the potential for using a dual-tracer approach to quantify receptor expression in tumors with abnormal hemodynamics, possibly to inform the choice or progress of molecular cancer therapies. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>© 2025 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=82560195
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1088/0031-9155/57/20/6647
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 6647
    Subjects:
      – SubjectFull: Tracers (Biology)
        Type: general
      – SubjectFull: Tissues -- Models
        Type: general
      – SubjectFull: Epidermal growth factor receptors
        Type: general
      – SubjectFull: Tumor treatment
        Type: general
      – SubjectFull: Molecular biology
        Type: general
      – SubjectFull: Gene expression
        Type: general
      – SubjectFull: Hemodynamics
        Type: general
    Titles:
      – TitleFull: Advantages of a dual-tracer model over reference tissue models for binding potential measurement in tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tichauer, K. M.
      – PersonEntity:
          Name:
            NameFull: Samkoe, K. S.
      – PersonEntity:
          Name:
            NameFull: Klubben, W. S.
      – PersonEntity:
          Name:
            NameFull: Hasan, T.
      – PersonEntity:
          Name:
            NameFull: Pogue, B. W.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 10
              Text: 10/21/2012
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-print
              Value: 00319155
          Numbering:
            – Type: volume
              Value: 57
            – Type: issue
              Value: 20
          Titles:
            – TitleFull: Physics in Medicine & Biology
              Type: main
ResultId 1